FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2227625267> ?p ?o ?g. }

• W2227625267 endingPage "401" @default.
• W2227625267 startingPage "394" @default.
• W2227625267 abstract "Abstract Background In spite of significant improvement after multi-modality treatment, prognosis of most patients with glioblastoma remains poor. Standard clinical prognostic factors (age, gender, extent of surgery and performance status) do not clearly predict long-term survival. The aim of this case-control study was to evaluate immuno-histochemical and genetic characteristics of the tumour as additional prognostic factors in glioblastoma. Patients and methods Long-term survivor group were 40 patients with glioblastoma with survival longer than 30 months. Control group were 40 patients with shorter survival and matched to the long-term survivor group according to the clinical prognostic factors. All patients underwent multimodality treatment with surgery, postoperative conformal radiotherapy and temozolomide during and after radiotherapy. Biopsy samples were tested for the methylation of MGMT promoter (with methylation specific polymerase chain reaction), IDH1 (with immunohistochemistry), IDH2, CDKN2A and CDKN2B (with multiplex ligation-dependent probe amplification), and 1p and 19q mutations (with fluorescent in situ hybridization). Results Methylation of MGMT promoter was found in 95% and in 36% in the long-term survivor and control groups, respectively (p < 0.001). IDH1 R132H mutated patients had a non-significant lower risk of dying from glioblastoma (p = 0.437), in comparison to patients without this mutation. Other mutations were rare, with no significant difference between the two groups. Conclusions Molecular and genetic testing offers additional prognostic and predictive information for patients with glioblastoma. The most important finding of our analysis is that in the absence of MGMT promoter methylation, longterm survival is very rare. For patients without this mutation, alternative treatments should be explored." @default.
• W2227625267 created "2016-06-24" @default.
• W2227625267 creator A5037779732 @default.
• W2227625267 creator A5037858126 @default.
• W2227625267 creator A5048805964 @default.
• W2227625267 creator A5054148877 @default.
• W2227625267 creator A5056940160 @default.
• W2227625267 creator A5060085184 @default.
• W2227625267 creator A5069562710 @default.
• W2227625267 creator A5081984497 @default.
• W2227625267 creator A5091905694 @default.
• W2227625267 date "2016-11-10" @default.
• W2227625267 modified "2023-10-16" @default.
• W2227625267 title "Long-term survival in glioblastoma: methyl guanine methyl transferase (MGMT) promoter methylation as independent favourable prognostic factor" @default.
• W2227625267 cites W1523980033 @default.
• W2227625267 cites W1544889021 @default.
• W2227625267 cites W1552123405 @default.
• W2227625267 cites W1893588436 @default.
• W2227625267 cites W1957103815 @default.
• W2227625267 cites W1964352665 @default.
• W2227625267 cites W1966611280 @default.
• W2227625267 cites W1973864599 @default.
• W2227625267 cites W1974754255 @default.
• W2227625267 cites W1983293427 @default.
• W2227625267 cites W1986736144 @default.
• W2227625267 cites W1992237071 @default.
• W2227625267 cites W1994497191 @default.
• W2227625267 cites W1995388727 @default.
• W2227625267 cites W1996538425 @default.
• W2227625267 cites W1996700599 @default.
• W2227625267 cites W2005026412 @default.
• W2227625267 cites W2016287862 @default.
• W2227625267 cites W2029308958 @default.
• W2227625267 cites W2038508635 @default.
• W2227625267 cites W2044980821 @default.
• W2227625267 cites W2052491055 @default.
• W2227625267 cites W2062183453 @default.
• W2227625267 cites W2064532505 @default.
• W2227625267 cites W2068563641 @default.
• W2227625267 cites W2092536854 @default.
• W2227625267 cites W2094386848 @default.
• W2227625267 cites W2096049398 @default.
• W2227625267 cites W2096287682 @default.
• W2227625267 cites W2101922439 @default.
• W2227625267 cites W2102964718 @default.
• W2227625267 cites W2104997807 @default.
• W2227625267 cites W2105100844 @default.
• W2227625267 cites W2121749405 @default.
• W2227625267 cites W2123299008 @default.
• W2227625267 cites W2129313368 @default.
• W2227625267 cites W2133865472 @default.
• W2227625267 cites W2141817885 @default.
• W2227625267 cites W2143476979 @default.
• W2227625267 cites W2156925988 @default.
• W2227625267 cites W2159485898 @default.
• W2227625267 cites W2159842626 @default.
• W2227625267 cites W2160382843 @default.
• W2227625267 cites W2161524493 @default.
• W2227625267 cites W2169590480 @default.
• W2227625267 cites W2171090689 @default.
• W2227625267 cites W2313506275 @default.
• W2227625267 cites W2322680351 @default.
• W2227625267 cites W4255289481 @default.
• W2227625267 doi "https://doi.org/10.1515/raon-2015-0041" @default.
• W2227625267 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5120572" @default.
• W2227625267 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27904447" @default.
• W2227625267 hasPublicationYear "2016" @default.
• W2227625267 type Work @default.
• W2227625267 sameAs 2227625267 @default.
• W2227625267 citedByCount "47" @default.
• W2227625267 countsByYear W22276252672017 @default.
• W2227625267 countsByYear W22276252672018 @default.
• W2227625267 countsByYear W22276252672019 @default.
• W2227625267 countsByYear W22276252672020 @default.
• W2227625267 countsByYear W22276252672021 @default.
• W2227625267 countsByYear W22276252672022 @default.
• W2227625267 countsByYear W22276252672023 @default.
• W2227625267 crossrefType "journal-article" @default.
• W2227625267 hasAuthorship W2227625267A5037779732 @default.
• W2227625267 hasAuthorship W2227625267A5037858126 @default.
• W2227625267 hasAuthorship W2227625267A5048805964 @default.
• W2227625267 hasAuthorship W2227625267A5054148877 @default.
• W2227625267 hasAuthorship W2227625267A5056940160 @default.
• W2227625267 hasAuthorship W2227625267A5060085184 @default.
• W2227625267 hasAuthorship W2227625267A5069562710 @default.
• W2227625267 hasAuthorship W2227625267A5081984497 @default.
• W2227625267 hasAuthorship W2227625267A5091905694 @default.
• W2227625267 hasBestOaLocation W22276252671 @default.
• W2227625267 hasConcept C104317684 @default.
• W2227625267 hasConcept C121608353 @default.
• W2227625267 hasConcept C126322002 @default.
• W2227625267 hasConcept C127848430 @default.
• W2227625267 hasConcept C143998085 @default.
• W2227625267 hasConcept C2776300330 @default.
• W2227625267 hasConcept C2777389519 @default.
• W2227625267 hasConcept C2780265364 @default.
• W2227625267 hasConcept C33288867 @default.
• W2227625267 hasConcept C501734568 @default.

• next